Analyst Ratings February 11, 2026

KeyBanc Lifts DuPont Target to $57, Citing Restructuring and Early Signs of Industrial Recovery

Analyst keeps Overweight rating as earnings beat and valuation support a higher target

By Caleb Monroe DD
KeyBanc Lifts DuPont Target to $57, Citing Restructuring and Early Signs of Industrial Recovery
DD

KeyBanc raised its price target on DuPont to $57 from $51 while retaining an Overweight rating, citing confidence in the company’s growth trajectory after portfolio reshaping. The firm pointed to consistent execution, initial 2026 guidance, early order growth, and an attractive valuation at 13.1 times estimated 2026 EBITDA as reasons for the change. DuPont’s recent quarter beat expectations on both EPS and revenue, and the stock has shown notable year-to-date gains.

Key Points

  • KeyBanc raised its DuPont price target to $57 from $51 and retained an Overweight rating, implying upside from the current $49.43 share price.
  • Analyst Aleksey Yefremov cited increased confidence in DuPont’s long-term growth following the portfolio restructuring after the Qnity divestiture, along with consistent execution and initial 2026 guidance.
  • DuPont’s valuation at 13.1 times estimated 2026 EBITDA, a 7% free cash flow yield, and a 55-year dividend payment streak are factors supporting the bullish view; recent Q4 2025 results beat EPS and revenue estimates.

KeyBanc has increased its price target for DuPont (NYSE:DD) to $57.00 from $51.00 and maintained an Overweight rating on the stock. The revised target implies upside from DuPont’s most recent share price of $49.43, which has risen 22.96% year-to-date.

In raising the target, KeyBanc analyst Aleksey Yefremov pointed to greater conviction in DuPont’s long-term growth algorithm following the company’s portfolio adjustments completed after the Qnity divestiture. The analyst cited steady operational execution in recent quarters and highlighted the company’s initial guidance for 2026 as evidence supporting a stronger earnings outlook.

KeyBanc also observed early signs of an industrial rebound, noting healthy order growth at the outset of the year. While the research team acknowledged that DuPont still has material exposure to sectors that remain challenged - specifically building, construction, and automotive - it expects those headwinds to be more than offset by mid-single-digit growth rates in the company’s healthcare and water segments.

Valuation played an important role in the firm’s decision. DuPont shares are currently trading at 13.1 times estimated 2026 EBITDA, a multiple KeyBanc described as attractive and supportive of its Overweight thesis and higher price target tied to an upgraded earnings forecast. Additional financial metrics cited include a 7% free cash flow yield and a track record of dividend payments sustained for 55 consecutive years. The company’s Financial Health score is characterized as "GREAT," and the shares are trading near what KeyBanc views as fair value.

Recent quarterly results lent further support to the positive momentum. For the fourth quarter of 2025, DuPont reported earnings per share of $0.46, topping the $0.43 estimate. Revenue for the quarter came in at $1.7 billion, marginally above the $1.69 billion forecast. Those results prompted a favorable response in pre-market trading following the release, with the company either meeting or exceeding analysts’ expectations on those measures.

Taken together, KeyBanc’s commentary frames the price target increase as a function of improved confidence in DuPont’s post-restructuring growth path, encouraging early indicators of industrial demand, and valuation measures that leave room for upside if earnings momentum continues. At the same time, the firm continues to monitor cyclical pressures in construction-related end markets and the automotive sector as potential constraints on performance.


Contextual note: The details above summarize KeyBanc’s published view, recent company results for the fourth quarter of 2025, and the market’s early reaction to those results.

Risks

  • Ongoing weakness in the building and construction sector could pressure demand for DuPont’s products - primarily impacting industrial and building-materials markets.
  • Exposure to the automotive sector remains a headwind and could limit upside if market conditions in auto do not improve as expected - affecting industrial and transportation-related revenues.
  • The positive thesis depends on mid-single-digit growth in healthcare and water segments to offset cyclical weakness; slower growth in those end markets would increase downside risk.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026